Other languages Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Market Closed - Nyse Other stock markets 04:00:01 2023-12-05 pm EST			5-day change	1st Jan Change
50.23 ^USD	+0.50%		+2.68%	-30.19%

Dec. 05	UniCredit seeks new chair candidate by early 2024, sources say	RE
Dec. 05	Bristol-Myers Squibb Says Application for Bladder Cancer Combo Therapy Gets Priority Review Status From US FDA	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

UniCredit seeks new chair candidate by early 2024, sources say	Dec. 05
Bristol-Myers Squibb Says Application for Bladder Cancer Combo Therapy Gets Priority Review Status From US FDA	Dec. 05
Bristol Myers : un examen prioritaire obtenu pour Opdivo	Dec. 05
Bristol Myers Squibb Announces U.S. Food and Drug Administration Accept the Supplemental Biologics License Application for Opdivo	Dec. 05
Blackstone explores sale of Anthos Therapeutics -sources	Dec. 04
Blackstone explora la venta de Anthos Therapeutics: fuentes	Dec. 04
Blackstone explores sale of Anthos Therapeutics -sources	Dec. 04
Bristol Myers Squibb Insider Bought Shares Worth $150,049, According to a Recent SEC Filing	Dec. 01
US FDA investigating safety risk of CAR-T cancer therapies	Nov. 28
FDA Probes T-Cell Malignancies in Patients Receiving CAR-T Cell Therapies	Nov. 28
Sector Update: Health Care Stocks Ease Tuesday Afternoon	Nov. 28
US FDA investigating safety risk of CAR-T therapies	Nov. 28
Sector Update: Health Care Stocks Decline Premarket Tuesday	Nov. 28
Sector Update: Health Care	Nov. 28
Traders Await Economic Data as US Equity Futures Post Narrow Losses Pre-Bell	Nov. 28
Avidity Biosciences Collaborates With Bristol Myers to Advance Use of AOC in Multiple Cardiac Targets	Nov. 28
Avidity Biosciences, Inc. Announces Expansion of Cardiovascular Collaboration with Bristol Myers Squibb for Up to Five Targets Utilizing Avidity's Proprietary AOC Platform Technology	Nov. 28
Bristol Myers Squibb Insider Bought Shares Worth $423,385, According to a Recent SEC Filing	Nov. 22
US Senate Health Committee Members Ask Johnson & Johnson, Merck, Bristol-Myers Squibb CEOs to Testify on Drug Pricing	Nov. 21
Bayer anticipe des impacts sur sa trésorerie après l'échec clinique de son anticoagulant	Nov. 21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Other languages Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Other languages

Filters